BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Amazon Biotech Today Announced Designation of Registered Agent Address and Management Update


4/6/2010 11:13:56 AM

WEST PALM BEACH, FL--(Marketwire - April 05, 2010) -

Amazon Biotech Inc (PINKSHEETS: AMZO) (FRANKFURT: B2DA) today announced the following:

The company management has designated the registered agent as V Corp Services LLC; 1760 South 110 East; Suite 1; Salt Lake City Utah 84105 -1-888-528-2677

The office USA address is 777 South Flagler drive suite 800 Florida 33401

The sole director is Chaim J. Lieberman. Tel 1-212-444-1019, Email cj@amazonbiotech.com

Please make sure any business including state, transfer agent, accounting, patents, etc. have the approval of Chaim J. Lieberman.

It is important to note, the founder of Amazon Biotech Inc in 2003 and its legal counsel Spectrum law group and all the state and SEC filings were based on directors being appointed, removed and replaced with majority shareholder vote not with a formal full shareholder meeting. It was based on this precedent that M Kanovsky was appointed and removed. If Michael Kanovsky feels that a full formal shareholder meeting was needed then he never was a director to begin with.

It is further noted that management has a verified signed and witnessed by two witnesses resignation letter from M Kanovsky.

The company has been unable to move forward due to refusal by M Kanovsky to recognize this. If you are interested to participate in a shareholder meeting to clarify the matter please contact cj@amazonbiotech.com

Safe Harbor Statement Under the Private Securities Litigation Reform Act Of 1995

This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause Amazon Biotech Inc's actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.


Contact:
Chaim J. Lieberman
Tel 1-212-444-1019
Email cj@amazonbiotech.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES